Cargando…
Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919467/ https://www.ncbi.nlm.nih.gov/pubmed/31942546 http://dx.doi.org/10.1097/HS9.0000000000000293 |
| _version_ | 1783480765201252352 |
|---|---|
| author | Momotow, Jesko Goergen, Helen Behringer, Karolin Bröckelmann, Paul J. Borchmann, Sven Tresckow, Bastian v. Kobe, Carsten Engert, Andreas Sasse, Stephanie |
| author_facet | Momotow, Jesko Goergen, Helen Behringer, Karolin Bröckelmann, Paul J. Borchmann, Sven Tresckow, Bastian v. Kobe, Carsten Engert, Andreas Sasse, Stephanie |
| author_sort | Momotow, Jesko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6919467 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69194672020-01-15 Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center Momotow, Jesko Goergen, Helen Behringer, Karolin Bröckelmann, Paul J. Borchmann, Sven Tresckow, Bastian v. Kobe, Carsten Engert, Andreas Sasse, Stephanie Hemasphere Letter Wolters Kluwer Health 2019-09-27 /pmc/articles/PMC6919467/ /pubmed/31942546 http://dx.doi.org/10.1097/HS9.0000000000000293 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
| spellingShingle | Letter Momotow, Jesko Goergen, Helen Behringer, Karolin Bröckelmann, Paul J. Borchmann, Sven Tresckow, Bastian v. Kobe, Carsten Engert, Andreas Sasse, Stephanie Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center |
| title | Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center |
| title_full | Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center |
| title_fullStr | Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center |
| title_full_unstemmed | Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center |
| title_short | Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center |
| title_sort | nivolumab in relapsed/refractory classical hodgkin lymphoma – extended follow-up of 30 patients treated within the checkmate 205 trial in a single-center |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919467/ https://www.ncbi.nlm.nih.gov/pubmed/31942546 http://dx.doi.org/10.1097/HS9.0000000000000293 |
| work_keys_str_mv | AT momotowjesko nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter AT goergenhelen nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter AT behringerkarolin nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter AT brockelmannpaulj nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter AT borchmannsven nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter AT tresckowbastianv nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter AT kobecarsten nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter AT engertandreas nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter AT sassestephanie nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter |